Johnson & Johnson to Pay $1.5B+ for Marketing Drug
Johnson & Johnson -- the company that helped you shampoo with "no more tears," fight acne , and heal pretty much every wound that didn't require stiches -- is close to a settlement with the federal government. It's going to pay a fine of more than $1.5 billion, sources say. For, essentially, speaking. The case comes out of J&J's prescription drug business. The Wall Street Journal explains :Under federal law, drug makers can market medicines only for uses approved by the U.S. Food and Drug Administration, though doctors can prescribe drugs for unapproved, or off-label, uses. The largest illegal-drug-marketing settlement to date was in 2009, when Pfizer Inc. agreed to pay $2.3 billion to resolve an investigation into the promotion of now-withdrawn painkiller Bextra and other drugs.

Jun 21, 2012
|